Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Biocept Inc (BIOCQ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.001 0.000    0.00%
- Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.000 - 0.001
Biocept 0.001 0.000 0.00%

BIOCQ Balance Sheet

 
Featured here, the Balance Sheet for Biocept Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
30/06
2023
31/03
2022
31/12
2022
30/09
Total Current Assets 8.86 9.09 16.34 27.26
Cash and Short Term Investments 6.63 6.77 12.9 18.02
Cash - - - -
Cash & Equivalents 6.63 6.77 12.9 18.02
Short Term Investments - - - -
Total Receivables, Net 0.8 1.11 2.15 6.4
Accounts Receivables - Trade, Net 0.8 1.11 2.15 6.4
Total Inventory 0.551 0.704 0.757 1.9
Prepaid Expenses 0.876 0.5 0.538 0.949
Other Current Assets, Total - - - -
Total Assets 22.1 22.99 30.87 41.73
Property/Plant/Equipment, Total - Net 12.86 13.52 14.14 14.08
Property/Plant/Equipment, Total - Gross 21.68 23.43 23.57 23.01
Accumulated Depreciation, Total -8.83 -9.91 -9.42 -8.94
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments - - - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 0.386 0.386 0.386 0.392
Other Assets, Total -0.249 -0.408 -1.39 -4.5
Total Current Liabilities 4.9 4.39 5.51 7.15
Accounts Payable 1.47 1.53 1.52 3.04
Payable/Accrued - - - -
Accrued Expenses 1.53 1.3 2.25 2.18
Notes Payable/Short Term Debt 0.526 - 0.117 0.384
Current Port. of LT Debt/Capital Leases 1.38 1.56 1.62 1.55
Other Current liabilities, Total - - - -
Total Liabilities 21.81 20.56 22.01 23.58
Total Long Term Debt 0.836 1.01 1.2 1.01
Long Term Debt - - - -
Capital Lease Obligations 0.836 1.01 1.2 1.01
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 15.02 15.16 15.07 14.66
Total Equity 0.29 2.43 8.86 18.15
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - 0.002 0.002 0.002
Additional Paid-In Capital 309.5 308.01 307.3 306.87
Retained Earnings (Accumulated Deficit) -309.21 -305.58 -298.44 -288.73
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - - - -
Total Liabilities & Shareholders' Equity 22.1 22.99 30.87 41.73
Total Common Shares Outstanding 2.41 0.593 0.569 0.569
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BIOCQ Comments

Write your thoughts about Biocept Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mary Hill
Mary Hill Nov 23, 2023 4:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow 5 cent 😳
Lotiful Islam babu
Lotiful Islam babu Oct 20, 2023 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will be 0.10
Fardad Gharibi
Fardad Gharibi May 23, 2023 9:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
soon will be +10 $
Joeri Houbrechts
Joeri Houbrechts Jul 08, 2022 3:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The only way is up
paola bastoni
paola bastoni Feb 18, 2022 3:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Record revenue expected
Josep Magrans Llop
Josep Magrans Llop Jan 22, 2022 5:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.proactiveinvestors.com/companies/news/971834/biocept-says-demand-for-its-covid-19-rt-pcr-testing-increases-in-2022-amid-omicron-variant-surge-971834.html
Josep Magrans Llop
Josep Magrans Llop Jan 22, 2022 5:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Biocept dice que la demanda de sus pruebas COVID-19 RT-PCR aumenta en 2022 en medio del aumento de variantes de OmicronBiocept continúa sirviendo a la comunidad con pruebas de alta calidad, habiendo recibido más de 40,000 muestras para pruebas de COVID-19 desde principios de 2022
Josep Magrans Llop
Josep Magrans Llop Dec 01, 2021 9:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.prnewswire.com/news-releases/quest-diagnostics-now-offers-biocepts-liquid-biopsy-test-for-lung-cancer-expanding-its-menu-of-advanced-cancer-diagnostics-301435081.html
Josep Magrans Llop
Josep Magrans Llop Oct 07, 2021 11:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.nasdaq.com/articles/7-of-the-best-penny-stocks-to-buy-coming-into-year-end-2021-09-21
Josep Magrans Llop
Josep Magrans Llop Oct 06, 2021 5:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
PROJECTION UNTIL  13$  https://invst.ly/w88nk
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email